Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers.
Saved in:
| Title: | Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers. |
|---|---|
| Authors: | Tian M; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Jia K; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Wu JT; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Cheuk AT; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Fang S; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA., Ojo VT; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA., Pope EG; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Milewski D; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kim YY; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Chou HC; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Kelekar A; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Dey S; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Yu Y; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA., Rahman MA; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA., Khan RMN; Clinical Pharmacology Lab, Clinical Center, National Institutes of Health Clinical Center, Bethesda, MD, USA., Arisa O; Clinical Pharmacology Lab, Clinical Center, National Institutes of Health Clinical Center, Bethesda, MD, USA., Figg WD; Clinical Pharmacology Lab, Clinical Center, National Institutes of Health Clinical Center, Bethesda, MD, USA; Clinical Pharmacology Program, Center for Cancer Research, National Institutes of Health Clinical Center, Bethesda, MD, USA., Sharan SK; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702, USA; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Ohler ZW; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Szabova L; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Difilippantonio S; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA., Shor B; Manhattan BioSolutions, Inc., New York, NY, USA., Tumey LN; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA., Wei JS; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: weij@mail.nih.gov., Khan J; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: khanjav@mail.nih.gov. |
| Source: | Cell reports. Medicine [Cell Rep Med] 2026 Jul 14, pp. 102922. Date of Electronic Publication: 2026 Jul 14. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Cell Press Country of Publication: United States NLM ID: 101766894 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2666-3791 (Electronic) Linking ISSN: 26663791 NLM ISO Abbreviation: Cell Rep Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42447867 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Tian+M%22">Tian M</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Jia+K%22">Jia K</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Wu+JT%22">Wu JT</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Cheuk+AT%22">Cheuk AT</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Fang+S%22">Fang S</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA.<br /><searchLink fieldCode="AU" term="%22Ojo+VT%22">Ojo VT</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA.<br /><searchLink fieldCode="AU" term="%22Pope+EG%22">Pope EG</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Milewski+D%22">Milewski D</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kim+YY%22">Kim YY</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Chou+HC%22">Chou HC</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Kelekar+A%22">Kelekar A</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Dey+S%22">Dey S</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Yu+Y%22">Yu Y</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Rahman+MA%22">Rahman MA</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA.<br /><searchLink fieldCode="AU" term="%22Khan+RMN%22">Khan RMN</searchLink>; Clinical Pharmacology Lab, Clinical Center, National Institutes of Health Clinical Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Arisa+O%22">Arisa O</searchLink>; Clinical Pharmacology Lab, Clinical Center, National Institutes of Health Clinical Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Figg+WD%22">Figg WD</searchLink>; Clinical Pharmacology Lab, Clinical Center, National Institutes of Health Clinical Center, Bethesda, MD, USA; Clinical Pharmacology Program, Center for Cancer Research, National Institutes of Health Clinical Center, Bethesda, MD, USA.<br /><searchLink fieldCode="AU" term="%22Sharan+SK%22">Sharan SK</searchLink>; Mouse Cancer Genetics Program, Center for Cancer Research, National Cancer Institute, NIH, Frederick, MD 21702, USA; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.<br /><searchLink fieldCode="AU" term="%22Ohler+ZW%22">Ohler ZW</searchLink>; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.<br /><searchLink fieldCode="AU" term="%22Szabova+L%22">Szabova L</searchLink>; Center for Advanced Preclinical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.<br /><searchLink fieldCode="AU" term="%22Difilippantonio+S%22">Difilippantonio S</searchLink>; Laboratory Animal Sciences Program, Frederick National Laboratory for Cancer Research, Frederick, MD 21702, USA.<br /><searchLink fieldCode="AU" term="%22Shor+B%22">Shor B</searchLink>; Manhattan BioSolutions, Inc., New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Tumey+LN%22">Tumey LN</searchLink>; School of Pharmacy and Pharmaceutical Sciences, Binghamton University, Binghamton, NY, USA.<br /><searchLink fieldCode="AU" term="%22Wei+JS%22">Wei JS</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: weij@mail.nih.gov.<br /><searchLink fieldCode="AU" term="%22Khan+J%22">Khan J</searchLink>; Oncogenomics Section, Genetics Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA. Electronic address: khanjav@mail.nih.gov. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%22101766894%22">Cell reports. Medicine</searchLink> [Cell Rep Med] 2026 Jul 14, pp. 102922. <i>Date of Electronic Publication: </i>2026 Jul 14. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Cell+Press%22">Cell Press </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101766894 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2666-3791 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226663791%22">26663791 </searchLink><i>NLM ISO Abbreviation: </i>Cell Rep Med <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42447867 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1016/j.xcrm.2026.102922 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: 102922 Titles: – TitleFull: Targeted antibody-drug conjugates for rhabdomyosarcoma and other FGFR4-expressing cancers. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Tian M – PersonEntity: Name: NameFull: Jia K – PersonEntity: Name: NameFull: Wu JT – PersonEntity: Name: NameFull: Cheuk AT – PersonEntity: Name: NameFull: Fang S – PersonEntity: Name: NameFull: Ojo VT – PersonEntity: Name: NameFull: Pope EG – PersonEntity: Name: NameFull: Milewski D – PersonEntity: Name: NameFull: Kim YY – PersonEntity: Name: NameFull: Chou HC – PersonEntity: Name: NameFull: Kelekar A – PersonEntity: Name: NameFull: Dey S – PersonEntity: Name: NameFull: Yu Y – PersonEntity: Name: NameFull: Rahman MA – PersonEntity: Name: NameFull: Khan RMN – PersonEntity: Name: NameFull: Arisa O – PersonEntity: Name: NameFull: Figg WD – PersonEntity: Name: NameFull: Sharan SK – PersonEntity: Name: NameFull: Ohler ZW – PersonEntity: Name: NameFull: Szabova L – PersonEntity: Name: NameFull: Difilippantonio S – PersonEntity: Name: NameFull: Shor B – PersonEntity: Name: NameFull: Tumey LN – PersonEntity: Name: NameFull: Wei JS – PersonEntity: Name: NameFull: Khan J IsPartOfRelationships: – BibEntity: Dates: – D: 14 M: 07 Text: 2026 Jul 14 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 2666-3791 Titles: – TitleFull: Cell reports. Medicine Type: main |
| ResultId | 1 |